Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris F Johnson

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Family Practice|January 11, 2022
New ways of working releasing general practitioner capacity with pharmacy prescribing support: a cost-consequence analysisChris F Johnson, Margaret Maskrey, Sean MacBride-Stewart, et al.
Family Practice|January 5, 2024
General practice pharmacist-led antipsychotic physical health monitoring: a prospective intervention scoping studyChris F Johnson, Fiona Ingram, Fiona Thomson, et al.
Pharmacy Practice|November 13, 2018
Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the communityChris F Johnson, Ola Ali Nassr, Catherine Harpur, et al.
BMJ Open|December 10, 2025
Study protocol for optimising antipsychotic prescribing among hospitalised patients in the acute care setting in Scotland: a national retrospective cohort studyCosmika Goswami, Tanja Mueller, Alexa Wall, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 6, 2012
Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort studyChris F Johnson, Hector J Macdonald, Pauline Atkinson, et al.
International Journal of Clinical Pharmacy|March 23, 2022
The standards of practice for delivery of polypharmacy and chronic disease medication reviews by general practice clinical pharmacists: a consensus studyKatie Earle-Payne, Paul Forsyth, Chris F Johnson, et al.
Therapeutic Advances in Psychopharmacology|April 30, 2025
The missing link? Pharmacists' perspectives on discontinuation of long-term antidepressants: a qualitative studyEllen Van Leeuwen, Els Mehuys, Chris F Johnson, et al.
BMC Family Practice|December 26, 2014
Patient factors associated with SSRI dose for depression treatment in general practice: a primary care cross sectional studyChris F Johnson, Nadine J Dougall, Brian Williams, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 26, 2024
'Flattened, fattened, and forgotten': the 'dis-integrated' care of patients prescribed antipsychotics in the UKAlan Woodall, Iain Buchan, Lauren E Walker, et al.
International Journal of Clinical Pharmacy|June 4, 2025
Evaluating a pharmacist-led cardio-renal-metabolic service to reduce healthcare inequities in a socioeconomically deprived population: a prospective intervention studyTania Ramos, Amit Verma, Iain Speirits, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Family Practice|January 11, 2022
New ways of working releasing general practitioner capacity with pharmacy prescribing support: a cost-consequence analysisChris F Johnson, Margaret Maskrey, Sean MacBride-Stewart, et al.
Family Practice|January 5, 2024
General practice pharmacist-led antipsychotic physical health monitoring: a prospective intervention scoping studyChris F Johnson, Fiona Ingram, Fiona Thomson, et al.
Pharmacy Practice|November 13, 2018
Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the communityChris F Johnson, Ola Ali Nassr, Catherine Harpur, et al.
BMJ Open|December 10, 2025
Study protocol for optimising antipsychotic prescribing among hospitalised patients in the acute care setting in Scotland: a national retrospective cohort studyCosmika Goswami, Tanja Mueller, Alexa Wall, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 6, 2012
Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort studyChris F Johnson, Hector J Macdonald, Pauline Atkinson, et al.
International Journal of Clinical Pharmacy|March 23, 2022
The standards of practice for delivery of polypharmacy and chronic disease medication reviews by general practice clinical pharmacists: a consensus studyKatie Earle-Payne, Paul Forsyth, Chris F Johnson, et al.
Therapeutic Advances in Psychopharmacology|April 30, 2025
The missing link? Pharmacists' perspectives on discontinuation of long-term antidepressants: a qualitative studyEllen Van Leeuwen, Els Mehuys, Chris F Johnson, et al.
BMC Family Practice|December 26, 2014
Patient factors associated with SSRI dose for depression treatment in general practice: a primary care cross sectional studyChris F Johnson, Nadine J Dougall, Brian Williams, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 26, 2024
'Flattened, fattened, and forgotten': the 'dis-integrated' care of patients prescribed antipsychotics in the UKAlan Woodall, Iain Buchan, Lauren E Walker, et al.
International Journal of Clinical Pharmacy|June 4, 2025
Evaluating a pharmacist-led cardio-renal-metabolic service to reduce healthcare inequities in a socioeconomically deprived population: a prospective intervention studyTania Ramos, Amit Verma, Iain Speirits, et al.
Pageof 3